Moreover, an ARID5B risk allele in B-ALL patients was associated with down regulation of ARID5B and mechanistic studies suggest that the risk allele affects the binding of the transcription factors MEF2C and RUNX3 (70, 71). Here, MEF2C is linked to acute lymphoblastic leukemia.